New Trends and Advances in Induced Neural Cells and iPSC Technologies
A special issue of Cells (ISSN 2073-4409). This special issue belongs to the section "Cellular Neuroscience".
Deadline for manuscript submissions: 28 August 2026 | Viewed by 2242
Editor
Interests: stem cell; induced pluripotent stem cell (iPSC); brain organoid; disease modeling; regenerative medicine; immune therapy; drug discovery
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Neurological disorders, and particularly neurodegenerative diseases, place a substantial burden on our aging society. Recent advances in induced pluripotent stem cell (iPSC) technology have opened unprecedented opportunities to study and model these conditions, providing a potentially unlimited source of cells for therapeutic applications. Precision genome editing represents a promising avenue to directly target and correct the underlying causes of disease. Emerging in vivo editing strategies, such as prime editing, enable precise modification of the human genome at specific loci. In parallel, the reprogramming of other cell types into neural cells (induced neural cells) offers an alternative and valuable source for cell-based therapies and drug discovery.
In this Special Issue, we invite original research articles and comprehensive reviews that showcase recent progress, innovative concepts, and breakthrough discoveries in these rapidly advancing fields. We hope that this collection will serve as a platform for disseminating cutting-edge developments and inspiring further innovation in neurological disease research and therapy.
Dr. Guoqiang Sun
Guest Editor
Jonas Cerneckis
Guest Editor Assistant
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-anonymized peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- induced neural cells
- induced pluripotent stem cell (iPSC)
- neurological disease modeling
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
